Ceisteanna ar Reachtaíocht a Gealladh - Questions on Promised Legislation
Dail Éireann — 2021-06-17
============================================================

Joan Collins (I4C), Dublin South-Central

Back in 2017 Orkambi was reimbursed for market distribution here in Ireland and it was a great boost for the cystic fibrosis, CF, community after a long campaign. A new drug, Kaftrio, has been approved in the USA and by the European Medicines Agency, EMA, in April of this year. I tabled a question to the Minister for Health in early May and I was told the applicants had put in the rapid review dossier for the drug. I flagged this with the Tánaiste yesterday because I hope the CF community will get some clarity today on when the Health Products Regulatory Authority, HPRA, will reimburse the drug and market it.

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/dail/2021-06-17/debate/main
Retrieved: 2026-08-14T04:49:24+00:00
Sitting date: 2021-06-17